Back to results
US 2020/0206133 A1Published application
Novel pharmaceutical compositions for basic or neutral, low molecular weight compounds
AssigneeHoffmann-La Roche Inc.
InventorsJochem ALSENZ, Martin KUENTZ, Alfred ROSS, Wiebke Svea SAAL, Nicole WYTTENBACH
Life of this patent
Estimating the term…
Abstract
The present invention provides novel, solid or liquid pharmaceutical preparations comprising a basic or neutral, low molecular weight active pharmaceutical ingredient and the polymer Eudragit® EPO, optionally together with additional pharmaceutically acceptable excipients. The present preparations are for oral or topical administration.
Claims15
1-10. (canceled)
A pharmaceutical preparation, comprising a lipophilic, basic or neutral, low molecular weight active pharmaceutical ingredient, and EPO, wherein the pharmaceutical preparation is solid or liquid.
Dependencies are inferred from the claim text.